We serve Maleic acid polymer CAS:26099-09-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Items of Analysis | Standard of Analysis | Test Results |
Appearance | Pale yellow to umber transparent liquid | Conform |
Solid content % | ≥48.0 | 50.50 |
Bromine value mg/g | ≤50.0 | 39.39 |
pH (10g/L solution) | 2.0-3.0 | 2.25 |
Density (20℃) g/cm3 | 1.22-1.25 | 1.234 |
Conclusion | Conforms to Factory Standard |
Contact us for information like Maleic acid polymer chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Belclene 200 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Nonpol PWA 50W Use and application,Aron A 6510 technical grade,usp/ep/jp grade.
Related News: Both Xinhua and the Global Times have published videos of drones warning various people in rural areas that masks need to be worn in “these times.” The drones were seen scolding an elderly lady and chasing a child down the road. N-tert-butoxycarbonyl-ε-(3-benzyloxy-1,4-dihydro-2-methyl-4-oxo-1-pyridyl)-L-norleucylglycyl-ε-(3-benzyloxy-1,4-dihydro-2-methyl-4-oxo-1-pyridyl)-L-norleucylglycine ethyl ester manufacturer You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.2-Piperidone supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 3-(1-benzyl-6-oxo-1,6-dihydro-9H-purin-9-yl)-N-(2-(2-(2-oxopyrrolidin-1-yl)acetamido)ethyl)propanamide vendor Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.